200 related articles for article (PubMed ID: 34987501)
21. Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1.
Giardino G; Lanni V; Mascolo M; Russo D; Cirillo E; Romano R; Cillo F; Grilli L; Prencipe MR; Iuliano A; Uccello G; De Fusco C; Menna G; Scalia G; Portella G; Pignata C
Front Immunol; 2024; 15():1370991. PubMed ID: 38633254
[TBL] [Abstract][Full Text] [Related]
22. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
23. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
[TBL] [Abstract][Full Text] [Related]
24. 2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection.
Pende D; Meazza R; Marcenaro S; Aricò M; Bottino C
Clin Immunol; 2019 Jul; 204():31-36. PubMed ID: 30391652
[TBL] [Abstract][Full Text] [Related]
25. Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the Literature.
Iglesias Cardenas F; Agarwal AM; Vagher J; Maese L; Fluchel M; Afify Z
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1210-e1213. PubMed ID: 33448720
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1.
An YF; Luo XB; Yang X; Wang J; Li L; Zhao XD
Pediatr Blood Cancer; 2014 Nov; 61(11):2043-7. PubMed ID: 25044636
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
[TBL] [Abstract][Full Text] [Related]
28. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
[TBL] [Abstract][Full Text] [Related]
30. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
[TBL] [Abstract][Full Text] [Related]
32. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
[TBL] [Abstract][Full Text] [Related]
33. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
35. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.
Arico M; Imashuku S; Clementi R; Hibi S; Teramura T; Danesino C; Haber DA; Nichols KE
Blood; 2001 Feb; 97(4):1131-3. PubMed ID: 11159547
[TBL] [Abstract][Full Text] [Related]
36. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
[TBL] [Abstract][Full Text] [Related]
37. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
Nagy N; Klein E
Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
[TBL] [Abstract][Full Text] [Related]
38. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
Tangye SG
J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
[TBL] [Abstract][Full Text] [Related]
39. Rare cause of Hemophagocytic Lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children - a case report with a review.
Sheth J; Patel A; Shah R; Bhavsar R; Trivedi S; Sheth F
BMC Pediatr; 2019 Mar; 19(1):73. PubMed ID: 30849948
[TBL] [Abstract][Full Text] [Related]
40. X-linked lymphoproliferative disease in an adult.
Hoshino T; Kanegane H; Doki N; Irisawa H; Sakura T; Nojima Y; Miyawaki S; Miyawaki T
Int J Hematol; 2005 Jul; 82(1):55-8. PubMed ID: 16105760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]